Could islet cell shots free type 1 diabetics from insulin?
NCT ID NCT06731218
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 23 times
Summary
This early-stage trial tests a new islet cell injection (RGB-5088) in 10 adults with type 1 diabetes who have severe low blood sugar episodes. The goal is to see if the treatment is safe and can help control blood sugar without insulin. Participants will be monitored for side effects and whether they can stop using insulin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin First Center Hospital
RECRUITINGTianjin, Tianjin Municipality, 300000, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.